» Articles » PMID: 27381728

Thyroid Dysfunction, Either Hyper or Hypothyroidism, Promotes Gallstone Formation by Different Mechanisms

Overview
Date 2016 Jul 7
PMID 27381728
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated comprehensively the effects of thyroid function on gallstone formation in a mouse model. Gonadectomized gallstone-susceptible male C57BL/6 mice were randomly distributed into three groups each of which received an intervention to induce hyperthyroidism, hypothyroidism, or euthyroidism. After 5 weeks of feeding a lithogenic diet of 15% (w/w) butter fat, 1% (w/w) cholesterol, and 0.5% (w/w) cholic acid, mice were killed for further experiments. The incidence of cholesterol monohydrate crystal formation was 100% in mice with hyperthyroidism, 83% in hypothyroidism, and 33% in euthyroidism, the differences being statistically significant. Among the hepatic lithogenic genes, Trβ was found to be up-regulated and Rxr down-regulated in the mice with hypothyroidism. In contrast, Lxrα, Rxr, and Cyp7α1 were up-regulated and Fxr down-regulated in the mice with hyperthyroidism. In conclusion, thyroid dysfunction, either hyperthyroidism or hypothyroidism, promotes the formation of cholesterol gallstones in C57BL/6 mice. Gene expression differences suggest that thyroid hormone disturbance leads to gallstone formation in different ways. Hyperthyroidism induces cholesterol gallstone formation by regulating expression of the hepatic nuclear receptor genes such as Lxrα and Rxr, which are significant in cholesterol metabolism pathways. However, hypothyroidism induces cholesterol gallstone formation by promoting cholesterol biosynthesis.

Citing Articles

Association between sleep and gallstone disease in United States adults: A cross-sectional study.

Zhuang Q, Cheng J, Wu S, Shen S, Huang D, Ning M BMC Public Health. 2024; 24(1):3291.

PMID: 39592967 PMC: 11600586. DOI: 10.1186/s12889-024-20824-y.


The correlation between urinary iodine levels and gallstone risk: elevated iodine intake linked to gallstone occurrence.

Li Y, Wang M, Du W, Qi L, Liu X, Fan X Front Nutr. 2024; 11:1412814.

PMID: 39114128 PMC: 11303756. DOI: 10.3389/fnut.2024.1412814.


Can Lipid-Lowering Drugs Reduce the Risk of Cholelithiasis? A Mendelian Randomization Study.

Dong H, Chen R, Xu F, Cheng F Clin Epidemiol. 2024; 16:131-141.

PMID: 38410417 PMC: 10896097. DOI: 10.2147/CLEP.S439642.


Gallstone Disease and Its Correlation With Thyroid Disorders: A Narrative Review.

Ravi P, Thugu T, Singh J, Dasireddy R, Kumar S, Isaac N Cureus. 2023; 15(9):e45116.

PMID: 37842424 PMC: 10568238. DOI: 10.7759/cureus.45116.


Sex-dependent difference in the relationship between thyroid hormones and gallstone disease in euthyroid subjects.

Liu G, Zheng X, Jia Y, Cao P, Jiang Z, Yang L Medicine (Baltimore). 2023; 102(23):e34007.

PMID: 37335641 PMC: 10256348. DOI: 10.1097/MD.0000000000034007.


References
1.
TEPPERMAN J, CALDWELL F, TEPPERMAN H . INDUCTION OF GALLSTONES IN MICE BY FEEDING A CHOLESTEROL-CHOLIC ACID CONTAINING DIET. Am J Physiol. 1964; 206:628-34. DOI: 10.1152/ajplegacy.1964.206.3.628. View

2.
Attili A, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L . Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology. 1997; 26(4):809-18. DOI: 10.1002/hep.510260401. View

3.
Hashimoto K, Mori M . Crosstalk of thyroid hormone receptor and liver X receptor in lipid metabolism and beyond [Review]. Endocr J. 2011; 58(11):921-30. DOI: 10.1507/endocrj.ej11-0114. View

4.
Vassilakis J, Nicolopoulos N . Dissolution of gallstones following thyroxine administration. A case report. Hepatogastroenterology. 1981; 28(1):60-1. View

5.
Portincasa P, Moschetta A, Palasciano G . Cholesterol gallstone disease. Lancet. 2006; 368(9531):230-9. DOI: 10.1016/S0140-6736(06)69044-2. View